Mucopolysaccharidosis type V
This type is also called Scheie syndrome and has been classified as a subtype of mucopolysaccharidosis type 1 because the enzyme defect in this disease is the same as that in type 1, and the genes and inheritance patterns of the two are also the same. This syndrome is characterized by normal intelligence, moderate bone changes, aortic valve disease, and nerve compression symptoms.
-
Site of disease:
Bone Heart Other -
Infectious :
Not contagious -
Frequent population:
child -
Related symptoms:
Corneal opacity sensory impairment joint stiffness edema corneal opacity -
Concurrent disease:
Related Drugs
Intestinal polysaccharide tablets
Indication: Used for coronary heart disease and atherosclerosis.
Manufacturer:
Shanghai Yan'an Pharmaceutical Co.
Intestinal polysaccharide tablets
Indication: Used for coronary heart disease and atherosclerosis.
Manufacturer:
Gansu Puerkang Pharmaceutical.,Ltd
Intestinal polysaccharide tablets
Indication: Used for coronary heart disease and atherosclerosis.
Manufacturer:
Gansu Puerkang Pharmaceutical.,Ltd
Intestinal polysaccharide tablets
Indication: Used for coronary heart disease and atherosclerosis.
Manufacturer:
Zhangzhou Biological Chemical & Pharmaceutical Plant Co., Ltd.